Barely Significant
← all excerpts

Efficacy of PD-1 blockade plus chemotherapy in patients with oncogenic-driven non-small-cell lung cancer.

Cancer Immunol Immunother · 2025 · PMC11787076 · PMID 39891730

Europe PMCDOI
1
hedged sentence
0.0140
closest p · 0.3× alpha
0.0140
boldest claim

The sentences

showed a trendP = 0.014actually significant
In the first line setting, although combination therapy generally showed a trend toward higher ORR across most mutation groups, statistical significance was observed only in the BRAF subgroup ( P = 0.014).

also in 11,799 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.